{"database": "lobbying", "table": "lobbying_activities", "rows": [[1332943, "fadb8fe5-d70d-4b22-a7a0-7fc0555331ee", "Q4", "VAN HEUVELEN STRATEGIES, LLC", 321874, "CVS HEALTH (FORMERLY KNOWN AS CVS CAREMARK)", 2012, "fourth_quarter", "PHA", "Issues related to prescription drug abuse, drug supply chain safety and prescriber education.\nH.R.2119, Ryan Creedon Act of 2011", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2013-01-11T13:45:21.560000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1332943"], "units": {}, "query_ms": 23.725269944407046, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}